Detailed information for compound 1088265

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 566.302 | Formula: C15H24N2O17P2
  • H donors: 10 H acceptors: 13 LogP: -7.76 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 4
  • SMILES: O[C@@H]1[C@@H](COP(=O)(OP(=O)(O[C@@H]2[C@H](O)[C@H](O)[C@H]([C@@H]([C@H]2O)O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
  • InChi: 1S/C15H24N2O17P2/c18-5-1-2-17(15(26)16-5)14-12(25)6(19)4(32-14)3-31-35(27,28)34-36(29,30)33-13-10(23)8(21)7(20)9(22)11(13)24/h1-2,4,6-14,19-25H,3H2,(H,27,28)(H,29,30)(H,16,18,26)/t4-,6-,7-,8-,9+,10-,11-,12-,13-,14-/m1/s1
  • InChiKey: SOMCFWHTBVRVAF-RFQXDUPDSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens purinergic receptor P2Y, G-protein coupled, 14 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis cyclins, putative 0.0117 0.4943 1
Loa Loa (eye worm) CMGC/CDK/CDC2 protein kinase 0.0049 0.0038 0.0038
Echinococcus multilocularis cyclins 0.0061 0.0867 0.0832
Trypanosoma cruzi cyclin 6, putative 0.0117 0.4943 1
Trichomonas vaginalis cyclins, putative 0.0061 0.0867 0.169
Echinococcus granulosus G2:mitotic specific cyclin B3 0.0187 1 1
Entamoeba histolytica cyclin, putative 0.0117 0.4943 1
Trypanosoma cruzi CYC2-like cyclin, putative 0.0117 0.4943 1
Echinococcus multilocularis G2:mitotic specific cyclin B3 0.0187 1 1
Loa Loa (eye worm) cyclin domain-containing protein 0.0187 1 1
Giardia lamblia G2/mitotic-specific cyclin B 0.0117 0.4943 1
Schistosoma mansoni cyclin B3 0.0187 1 1
Trichomonas vaginalis cyclin B, putative 0.0117 0.4943 1
Echinococcus multilocularis cyclins 0.0061 0.0867 0.0832
Echinococcus granulosus cyclins 0.0061 0.0867 0.0832
Trypanosoma cruzi cyclin, putative 0.0117 0.4943 1
Trichomonas vaginalis conserved hypothetical protein 0.0061 0.0867 0.169
Loa Loa (eye worm) hypothetical protein 0.0117 0.4943 0.4943
Onchocerca volvulus 0.0117 0.4943 0.5
Loa Loa (eye worm) CMGC/CDK/CDK5 protein kinase 0.0049 0.0038 0.0038
Echinococcus granulosus cyclins 0.0061 0.0867 0.0832
Trichomonas vaginalis cyclins, putative 0.0117 0.4943 1
Loa Loa (eye worm) hypothetical protein 0.0056 0.0572 0.0572
Trichomonas vaginalis cyclin D, putative 0.0061 0.0867 0.169
Echinococcus granulosus cyclin B3 1 0.0061 0.0867 0.0832
Brugia malayi Cyclin, N-terminal domain containing protein 0.0117 0.4943 0.4924
Echinococcus granulosus cyclins 0.0061 0.0867 0.0832
Leishmania major CYC2-like cyclin, putative,cyclin 6, putative 0.0117 0.4943 1
Giardia lamblia Hypothetical protein 0.0061 0.0867 0.169
Leishmania major cyclin 0.0117 0.4943 1
Giardia lamblia Cyclin A 0.0061 0.0867 0.169
Echinococcus granulosus cyclin B 0.0117 0.4943 0.4924
Echinococcus multilocularis cyclins 0.0061 0.0867 0.0832
Trypanosoma brucei mitotic cyclin 6 0.0117 0.4943 1
Echinococcus granulosus cyclins 0.0061 0.0867 0.0832
Trypanosoma cruzi cyclin, putative 0.0117 0.4943 1
Echinococcus multilocularis cyclin b3 0.0061 0.0867 0.0832
Trichomonas vaginalis cyclin B, putative 0.0117 0.4943 1
Echinococcus multilocularis cyclin B 0.0117 0.4943 0.4924
Loa Loa (eye worm) CMGC/CDK/CDC2 protein kinase 0.0049 0.0038 0.0038
Entamoeba histolytica cyclin, putative 0.0061 0.0867 0.169
Echinococcus multilocularis cyclins 0.0061 0.0867 0.0832
Trichomonas vaginalis cyclins, putative 0.0117 0.4943 1
Plasmodium falciparum cyclin 0.0061 0.0867 1
Entamoeba histolytica cyclin family protein 0.0061 0.0867 0.169
Trichomonas vaginalis cyclin B, putative 0.0117 0.4943 1
Brugia malayi Cyclin, N-terminal domain containing protein 0.0117 0.4943 0.4924
Entamoeba histolytica cyclin family protein 0.0061 0.0867 0.169
Trichomonas vaginalis cyclin B, putative 0.0117 0.4943 1
Echinococcus granulosus cyclin b3 0.0061 0.0867 0.0832
Schistosoma mansoni cyclins 0.0061 0.0867 0.0832
Trichomonas vaginalis cyclin A, putative 0.0117 0.4943 1
Schistosoma mansoni cyclin B 0.0117 0.4943 0.4924
Plasmodium vivax protein kinase Crk2 0.0049 0.0038 0.5
Echinococcus multilocularis cyclins 0.0061 0.0867 0.0832
Trichomonas vaginalis cyclin B3, putative 0.0061 0.0867 0.169
Trichomonas vaginalis cyclins, putative 0.0117 0.4943 1
Echinococcus multilocularis cyclins 0.0061 0.0867 0.0832
Echinococcus multilocularis cyclin B3 1 0.0061 0.0867 0.0832
Loa Loa (eye worm) hypothetical protein 0.0117 0.4943 0.4943
Trichomonas vaginalis cyclins, putative 0.0071 0.1627 0.324
Trichomonas vaginalis cyclin B, putative 0.0061 0.0867 0.169
Echinococcus multilocularis cyclins 0.0061 0.0867 0.0832
Trichomonas vaginalis cyclin D, putative 0.0061 0.0867 0.169
Echinococcus granulosus cyclins 0.0061 0.0867 0.0832
Toxoplasma gondii cell-cycle-associated protein kinase CDK, putative 0.0049 0.0038 0.5

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) Agonist activity at human P2Y2 receptor expressed in human 1321N1 cells up to 10 uM ChEMBL. 19502066
EC50 (functional) = 1.88 uM Agonist activity at human P2Y14 receptor expressed in human COS7 cells ChEMBL. 19502066

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.